98 related articles for article (PubMed ID: 1057698)
1. Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia.
Fürst P; Bergström J; Gordon A; Johnsson E; Zimmerman L
Kidney Int Suppl; 1975 Feb; (3):272-5. PubMed ID: 1057698
[No Abstract] [Full Text] [Related]
2. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
Gordon A; Berström J; Fürst P; Zimmerman L
Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
[No Abstract] [Full Text] [Related]
3. Middle molecules in uremic serum, urine and dialysis fluid.
Migone L; Dall'taglio P; Buzio C
Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.
Peters JH; Gotch FA; Keen M; Berridge BJ; Chao WR
Trans Am Soc Artif Intern Organs; 1974; 20 B():417-23. PubMed ID: 4450293
[No Abstract] [Full Text] [Related]
5. Middle molecules in uraemia.
Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
[No Abstract] [Full Text] [Related]
6. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
[TBL] [Abstract][Full Text] [Related]
7. Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl).
Pogglitsch H; Petek W; Waller J; Stübchen-Kirchner H
Wien Klin Wochenschr; 1977 Dec; 89(24):812-9. PubMed ID: 595605
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a 1100-1300 MW uremic neurotoxin.
Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
[No Abstract] [Full Text] [Related]
9. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
Zimmerman L; Baldesten A; Bergström J; Fürst P
Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
[TBL] [Abstract][Full Text] [Related]
10. Determination of endogenous middle molecules in normal and uremic body fluids.
Fürst P; Zimmerman L; Bergström J
Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
[TBL] [Abstract][Full Text] [Related]
11. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
Nesse AB; Arrizurieta de Muchnik E
Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
[No Abstract] [Full Text] [Related]
12. [Approach to elaborating immunochemical methods for removing peptides from the blood of kidney failure patients].
Sadykov AS; Salikhov ShI; Mikhamedieva ShG; Kasymov ShK; Pak NP
Biull Eksp Biol Med; 1984 Aug; 98(8):245-7. PubMed ID: 6466865
[TBL] [Abstract][Full Text] [Related]
13. Studies on the molecular etiology of uremia.
Gotch FA; Sargent JA; Peters JH
Kidney Int Suppl; 1975 Feb; (3):276-9. PubMed ID: 1057699
[No Abstract] [Full Text] [Related]
14. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of solute removal in hemodialysis.
Gotch FA
Adv Exp Med Biol; 1987; 223():227-37. PubMed ID: 3328954
[No Abstract] [Full Text] [Related]
16. Determination of middle molecules in uremic patients.
Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
[No Abstract] [Full Text] [Related]
17. Extracorporeal strategies for the removal of middle molecules.
Winchester JF; Audia PF
Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
[TBL] [Abstract][Full Text] [Related]
18. Intracellular free amino acids in uremic patients as influenced by amino acid supply.
Bergström J; Fürst P; Norée LO; Vinnars E
Kidney Int Suppl; 1975 Feb; (3):345-8. PubMed ID: 1057709
[No Abstract] [Full Text] [Related]
19. Intracellular amino acids in uremia.
Alvestrand A; Fürst P; Bergström J
Kidney Int Suppl; 1983 Dec; 16():S9-16. PubMed ID: 6429407
[TBL] [Abstract][Full Text] [Related]
20. Muscle intracellular electrolytes in patients with chronic uremia.
Bergström J; Alvestrand A; Fürst P; Hultman E; Widstam-Attorps U
Kidney Int Suppl; 1983 Dec; 16():S153-60. PubMed ID: 6588246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
